Unosi
Search full-text
"Jelica Vučićević"
-
Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs (2016)
Ž. Gagić, B. Ivković, T. Srdic-Rajic, J. Vucicevic, K. Nikolic, D. Agbaba, Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol. 88, pp. 59 - 69, 2016 -
3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity (2017)
J. Oluic, K. Nikolic, J. Vucicevic, Z. Gagic, S. Filipic, D. Agbaba, 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity, COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, Vol. 20, No. 4, pp. 292 - 303, 2017 -
The synthesis of amino acid analog of vitamin E (2014)
Ž. Gagić, B. Ivković, J. Vucicević, D. Agbaba, K. Nikolić, The synthesis of amino acid analog of vitamin E, Proceedings, pp. 1149 - 1152, 2014 -
Application of different in vitro techniques for predicting blood brain barrier pentration of imidazoline receptor ligands (2015-05)
J. Vučićević, M. Popović, K. Nikolić, S. Filipić, Ž. Gagić, D. Agbaba, Application of different in vitro techniques for predicting blood brain barrier pentration of imidazoline receptor ligands, Abstract book, May, 2015 -
Targeting the PI3K/mTOR pathway as an antitumor strategy: 3D-QSAR study and design of dual PI3K/mTOR inhibitors (2016-07)
J. Oluic, K. Nikolic, J. Vucicevic, Z. Gagic, S. Filipic, D. Agbaba, Targeting the PI3K/mTOR pathway as an antitumor strategy: 3D-QSAR study and design of dual PI3K/mTOR inhibitors, Book of the abstracts, Jul, 2016 -
QSAR modeling and structure based virtual screening for the selection of new PI3K/mTOR inhibitors as potential anticancer agents (2017)
J. Oluic, K. Nikolić, J. Vucicevic, Ž. Gagić, S. Filipic, D. Agbaba, QSAR modeling and structure based virtual screening for the selection of new PI3K/mTOR inhibitors as potential anticancer agents, CMBEBIH 2017: Proceedings of the International Conference on Medical and Biological Engineering 2017, pp. 379 - 383, 2017